Thank you, Caterina, and good morning. Also from my side, before we jump into the numbers, I will open up a bit on the changes that we have in the financial reporting from this year. Uh, we have not changed the reporting segments. They are still distribution and wholesale.
Uh, however, we have some new key financial indicators that we follow and we will also report them to you. First of all, the sales margin is a very important KPI for Oriola to follow. Uh, and the sales margin actually comes from the distribution and service fees that we invoice. It's also the entire portion of the wholesale sale, minus the cost of goods that we earn. And then, of course, it's also the advisory sales. So a combination of these three is the sales margin.
Then we have changed from reporting adjusted EBIT to adjusted EBITDA. The reason for that is more or less that we have the ERP treated as a cost during this year, and some other factors affecting it make it easier to follow the EBITDA compared to the adjusted EBIT. We have added free cash flow in the reporting, and on April 1st, we also announced that we had completed the sale of Svensk dos. We have included Svensk dos in the numbers for '24 and Q1 '25, which had a very limited impact on the full year, with 100,000 in '24 and 200,000 plus in '25. If we then move to the numbers, we had a strong organic growth of 8%, and the invoicing grew by 10%. Still, if we look at the net sales growth itself, there's an impact from the customer moving from consignment stock to inventory last year. However, the organic growth was 8%. If we then move to look at the sales margin, the sales margin was driven by the distribution segment. We had growth from 40 million to 41 million, a 4% increase. And we had a small decline in the sales margin on the wholesale side. If we then look at the EBITDA, the reported EBITDA declined from 6.7 million to 6 million. The main reason for that is that we had more adjusting items this year than last year. The adjusting items are mainly related to the new ERP. We had a cost of 1.3 million in quarter one. If we then look at the total adjusted EBITDA, it was 7.7 million compared to 7.5 million. And then we have from Sweden last year in the first quarter, which had a negative result, and a slightly positive result in the first quarter of 2025, which also gives a positive impact. So there was a small decline in adjusted EBITDA compared to last year. Then if we go into details on the adjusted EBITDA, you can see that. Those in Sweden being a part of the distribution segment, if we take that impact from quarter one out, it was, as I said, 500,000 minus last year, and now 200,000 plus. So the impact was 700,000. Then the distribution business itself added 100,000. And then we had a negative result at the EBITDA level in the wholesale segment. And then we had some group items and we ended up at 7.5 million in adjusted EBITDA.
If we then move into the segments.
As said, we had a good growth of 8%. Organic growth and invoicing grew by 10%.
If we look at the adjusted EBITDA in the distribution segment, we had net sales growth, as mentioned, and we achieved a very good product and service mix sold. So, the result was good. Uh, then on the other hand, we had some more costs, uh, for ensuring Oriola's operations were optimal with a stable and predictable volume and workload.
In that way, we can be very productive and efficient in our business. And now we had some fluctuations and volatility in customer behavior.
So, that gave us additional costs which negatively affected our cost base. And then we also had the Sweden impact. Uh, impact of 700,000 in adjusted EBITDA for the distribution segment.
If we look at the wholesale segment, there was a good growth of 9%. Uh, we had especially good growth in Sweden.
Uh, the Finnish wholesale was affected by a weaker market.
We had customers stockpiling in December, and there was a strike in the retail sector for a few days in quarter one.
So, we had actually the first two months that were a bit slower, and then March was already much better.
If we look at the adjusted EBITDA, there was a decline mainly related to the product mix and higher operating expenses. Part of those we have planned to invest for growth. But we can see that. The result did not pass through due to the mix and the higher costs than the base earlier. If we then look at the group again, examining the net profit, we can see that the EBITDA was lower than last year, mainly due to the higher costs in the ERP project compared to last year. Uh, we had a. Write down of when we sold the Svensk dos business, there was an impairment write down of 5.7 million in total, which affected the impairments we had. The EBIT was negative.
Then we had financial.
Financial expenses were lower than last year due to the lower debt level. Then we had a smaller loss in the joint venture with Kronans Apotek. And that was mainly related to real cost savings, but also partly related to some phasing of costs.
In the company. But the good development continues. Then if we look at the free cash flow, compared to last year, we had a very good positive change in working capital.
So we had a free cash flow of 25 million compared to minus ten million last year. And that, of course, affects the interest.
Net interest-bearing debt is 64 million. We have a lower debt level than last year. And the cash and cash equivalents amount to 135 million. Uh, we have a solid financial position.
We have quite a lot of non-cash impact from impairments during the last year. And the equity ratio has declined to 14%. But on the other hand, with the good cash flow, the gearing is -48% impacting that.
Kronans Apotek reported strong net sales growth, with particularly notable double-digit growth in e-commerce. As said, part of the profitability improvement is related to cost savings partly phasing, but it was still a good quarter for Kronans Apotek. We also had the AGM on the 2nd of April and we have now combined.
It was approved to combine the share classes, and that has been done. So now we have only one share class out on the market. We have also refined the Outlook. We say we have now.
It's just we are not talking about the Svensk dos anymore.
So we have included and expect to include Svensk dos in the numbers for last year and this first quarter. And we expect the EBITDA to increase from the previous year.
And in 2024, it was 33.4 million.
All right.